NO162241C - Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker. - Google Patents

Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker.

Info

Publication number
NO162241C
NO162241C NO842287A NO842287A NO162241C NO 162241 C NO162241 C NO 162241C NO 842287 A NO842287 A NO 842287A NO 842287 A NO842287 A NO 842287A NO 162241 C NO162241 C NO 162241C
Authority
NO
Norway
Prior art keywords
jod125
dimmunological
estradia
steroids
research
Prior art date
Application number
NO842287A
Other languages
English (en)
Other versions
NO842287L (no
NO162241B (no
Inventor
Alain Jouquey
Jean Salmon
Michel Mouren
Gaetan Touyer
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8309812A external-priority patent/FR2549067B1/fr
Priority claimed from FR8310142A external-priority patent/FR2548192B1/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO842287L publication Critical patent/NO842287L/no
Publication of NO162241B publication Critical patent/NO162241B/no
Publication of NO162241C publication Critical patent/NO162241C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO842287A 1983-06-14 1984-06-07 Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker. NO162241C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8309812A FR2549067B1 (fr) 1983-06-14 1983-06-14 Derives estradieniques radioactifs marques au tritium, leur procede de preparation et leur application pour l'etude et le dosage radio-immunologique de steroides dans les fluides biologiques
FR8310142A FR2548192B1 (fr) 1983-06-20 1983-06-20 Derives estradieniques radioactifs marques a l'iode, leur procede de preparation et leur application aux dosages radioimmunologiques

Publications (3)

Publication Number Publication Date
NO842287L NO842287L (no) 1984-12-17
NO162241B NO162241B (no) 1989-08-21
NO162241C true NO162241C (no) 1989-11-29

Family

ID=26223479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842287A NO162241C (no) 1983-06-14 1984-06-07 Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker.

Country Status (5)

Country Link
US (1) US4639336A (no)
EP (1) EP0131491A1 (no)
CA (1) CA1226573A (no)
FI (1) FI842399A (no)
NO (1) NO162241C (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285866C (en) * 1984-10-19 1991-07-09 Akiko Kubodera Immunoassay for estriol-3-sulfate
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
FR2627588A1 (fr) * 1988-02-24 1989-08-25 Ire Medgenix Sa Procede de dosage immunologique d'une substance de structure haptenique
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
JP2008504216A (ja) * 2003-12-02 2008-02-14 サイトイミューン サイエンシズ インコーポレイテッド モノクローナル抗体の生成のための方法および組成物
JP4833862B2 (ja) * 2004-01-28 2011-12-07 サイトイミューン サイエンシズ インコーポレイテッド 官能化コロイド金属組成物および方法
CN102203002A (zh) * 2007-09-21 2011-09-28 细胞免疫科学公司 纳米治疗性胶态金属组合物和方法
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
US7960145B2 (en) * 2007-11-08 2011-06-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2467477A (en) * 1976-05-10 1978-11-02 Beckman Instruments Inc 1125 imidazole steroid derivatives
US4358435A (en) * 1980-06-09 1982-11-09 The Research Foundation Of State University Of New York Ligand compositions and processes for their manufacture and their use in radioimmunoassay
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained

Also Published As

Publication number Publication date
US4639336A (en) 1987-01-27
CA1226573A (fr) 1987-09-08
NO842287L (no) 1984-12-17
FI842399A0 (fi) 1984-06-13
EP0131491A1 (fr) 1985-01-16
NO162241B (no) 1989-08-21
FI842399A (fi) 1984-12-15

Similar Documents

Publication Publication Date Title
NO870572D0 (no) Fremgangsmaate og innretning for finfordeling av malm med lavt energiforbruk.
NO166588C (no) Nye katalysepreparater, samt deres anvendelse ved fremstilling av polymerer.
NO871729L (no) Fremgangsmaate for aa frembringe paasproeytede belegg, apparat for gjennomfoering av fremgangsmaaten og gjenstander tilvirket i samsvar med fremgangsmaaten.
IT8124835A0 (it) Nuovi derivati di nor-tropano e granatano, loro procedimento di preparazione e loro applicazione in terapia.
BR8705281A (pt) Gene degradante de haloarilnitrila,seu uso,e celulas contendo o mesmo
NO159939C (no) Varmelagringsmateriale med reversibel flytende/fast-faseforandring og anvendelse derav.
DK396885A (da) Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen
NO162241C (no) Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker.
DE3481624D1 (de) Fluessige reaktivfarbstoffzubereitungen und ihre verwendung.
DK507685D0 (da) Tricycliske pyridinderivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige udgangsmaterialer
NO862975L (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
DK158522C (da) Beta-amylase, samt fremstilling og anvendelse deraf
DK621486A (da) 1-benzensulfonyl-2-oxo-5-alkoxypyrrolidinderivater samt deres fremstilling, anvendelse og praeparater med indhold deraf
NO820213L (no) Kjemiske forbindelser, deres fremstilling og deres anvendelse i legemidler
DK445187A (da) Apparat til undersoegelse af fejl i materialer, isaer i stoebegods
IT1130748B (it) Procedimento per il riscaldamento di locali e/o di acqua,con l'impiego di captatori solari,e dispositivo in particolarme per il condizionamento di locali,utilizzante il detto procedimento
NO153098C (no) 3-substituerte 2,2-dimethyl-cyclopropancarboxylsyrer og lavere alkylestere derav som er anvendelige som utgangsmaterialer ved fremstilling av pyrethroider med insekticid virkning
DK389086D0 (da) Pulver-azopigmenter med forbedrede rheologiske egenskaber, fremgangsmaade til deres fremstilling, samt deres anvendelse
IT8921789A0 (it) Reattivo per la ricerca e la determinazione della bilirubina nelle urine.
NO166726C (no) Fremgangsmaate for fremstilling av arylglycidyletere og 3-substituerte 1-alkylamino-2-propanoler.
IT1153062B (it) Derivati benzilidenici, loro preparazione e loro applicazione in terapia
DE3682105D1 (de) Probe, tracers, immunogene und antikoerper von ethosuximid.
NO823883L (no) Nye p-fenylendiaminer, deres fremstilling og anvendelse
DK545687A (da) Anti-idiotype antistoffer, fremgangsmaade til deres fremstilling samt analysefremgangsmaader med udnyttelse af disse antistoffer
FI863404A0 (fi) Kardiotoniska fosfodiesterasinhibitorer i komplex med vattenloesliga vitaminer.